ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.848,77
-0,34%
S&P 500
5.974,07
0,73%
Dow Jones
42.906,95
0,00%
Euro vs US Dollar
1,04012
-0,03%
Bitcoin
94.118,72
-0,60%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Scorpius Holdings Inc (SCPX)

  7. Scorpius Holdings Inc (SCPX) News

SCPX

Scorpius (SCPX)

Scorpius Holdings Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:SCPX
DatumZeitQuelleÜberschriftSymbolFirma
23/12/202422h15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:SCPXScorpius Holdings Inc
23/12/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:SCPXScorpius Holdings Inc
18/12/202412h09Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:SCPXScorpius Holdings Inc
11/12/202422h05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:SCPXScorpius Holdings Inc
09/12/202423h26Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:SCPXScorpius Holdings Inc
06/12/202412h00Edgar (US Regulatory)Form 8-K - Current reportAMEX:SCPXScorpius Holdings Inc
03/12/202422h30Edgar (US Regulatory)Form 8-K - Current reportAMEX:SCPXScorpius Holdings Inc
19/11/202413h30GlobeNewswire Inc.Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring ModelAMEX:SCPXScorpius Holdings Inc
14/11/202422h19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:SCPXScorpius Holdings Inc
14/11/202422h15GlobeNewswire Inc.Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward ProfitabilityAMEX:SCPXScorpius Holdings Inc
14/11/202422h13Edgar (US Regulatory)Form 8-K - Current reportAMEX:SCPXScorpius Holdings Inc
04/11/202413h30GlobeNewswire Inc.Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership AgreementAMEX:SCPXScorpius Holdings Inc
31/10/202412h30GlobeNewswire Inc.Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million AnnuallyAMEX:SCPXScorpius Holdings Inc
22/10/202414h00GlobeNewswire Inc.Scorpius Holdings Announces Partnership with U.S. Biotech CompanyAMEX:SCPXScorpius Holdings Inc
02/10/202414h00GlobeNewswire Inc.Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear ThreatsAMEX:SCPXScorpius Holdings Inc
30/09/202414h00GlobeNewswire Inc.Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing OpportunitiesAMEX:SCPXScorpius Holdings Inc
26/09/202422h05Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:SCPXScorpius Holdings Inc
12/09/202414h00GlobeNewswire Inc.Scorpius Holdings Commends the U.S. House of Representatives’ Passage of the BIOSECURE ActAMEX:SCPXScorpius Holdings Inc
09/09/202414h30GlobeNewswire Inc.Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDAAMEX:SCPXScorpius Holdings Inc
26/08/202414h00GlobeNewswire Inc.Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced Manufacturing Capabilities, and Path Toward Positive Cash FlowAMEX:SCPXScorpius Holdings Inc
26/08/202412h01Edgar (US Regulatory)Form 8-K - Current reportAMEX:SCPXScorpius Holdings Inc
20/08/202415h15GlobeNewswire Inc.Scorpius Holdings Achieves 16% Year-Over-Year Increase in Revenue for the Second Quarter of 2024AMEX:SCPXScorpius Holdings Inc
19/08/202423h24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:SCPXScorpius Holdings Inc
19/08/202422h47Edgar (US Regulatory)Form 8-K - Current reportAMEX:SCPXScorpius Holdings Inc
19/08/202419h08GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Closing of Public OfferingAMEX:SCPXScorpius Holdings Inc
16/08/202422h41Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]AMEX:SCPXScorpius Holdings Inc
16/08/202415h50GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Pricing of Public OfferingAMEX:SCPXScorpius Holdings Inc
15/08/202422h00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBAMEX:SCPXScorpius Holdings Inc
09/08/202423h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:SCPXScorpius Holdings Inc
09/08/202421h38GlobeNewswire Inc.Scorpius Holdings, Inc. Provides Update on its Previously Announced Public OfferingAMEX:SCPXScorpius Holdings Inc
 Showing the most relevant articles for your search:AMEX:SCPX

Kürzlich von Ihnen besucht

TG
432
Arbor Metals
COIN
DOGEUSD
Dogecoin
NYSE
XOM
Exxon Mobil
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
JPM
JP Morgan Chase
TG
MBG
MercedesBenz
TG
RHM
Rheinmetall
DBI
SDXP
SDAX
NYSE
MCD
McDonalds
FX
EURGBP
Euro vs Sterling
AMEX
XLV
Health Care Select Sector
COIN
XRPUSD
Ripple
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten